Pregabalin in outpatient detoxification of subjects with mild‐to‐moderate alcohol withdrawal syndrome
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Objective: In this open, prospective study we aimed to investigate the efficacy, medical safety and practicability of pregabalin in outpatient detoxification of alcohol‐dependent patients with mild‐to‐moderate alcohol withdrawal syndrome (AWS). Craving reduction, improvement of psychiatric symptoms and quality of life were the secondary endpoints. Methods: Forty alcohol dependent patients (DSM‐IV) were detoxified receiving 200–450 mg of pregabalin. Withdrawal (Clinical Institute Withdrawal Assessment for Alcohol (CIWA‐Ar)) and craving (Visual Analogue Scale (VAS); Obsessive and Compulsive Drinking Scale (OCDS)) rating scales were applied; psychiatric symptoms and quality of life were evaluated using the Symptom Check List‐90 Revised (SCL‐90‐R) and the QL‐Index, respectively. Relapsed and abstinent patients in the post‐detoxification evaluation have been compared. Results: Alcohol withdrawal symptoms and craving for alcohol resulted significantly reduced (p < 0.001) over time after pregabalin treatment. Pregabalin also resulted in a favourable improvement in psychiatric symptoms and quality of life (p < 0.001). Conclusions: To our knowledge, this is the first open, prospective study, about the possible use of pregabalin as an outpatient detoxification agent. These preliminary data show its efficacy and safety in the management of patients with mild‐to‐moderate AWS. Copyright © 2010 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SULLIVAN, J. T., SYKORA, K., SCHNEIDERMAN, J., NARANJO, C. A., & SELLERS, E. M. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb00737.x · Cited by 1,988 · cited 3×
“…more than 80 g of alcohol during the previous 24 h; a blood alcohol concentration lower than 0.1 g/L before the first assessment; a CIWAAr (Clinical Institute Withdrawal Assessment for Alcohol) score between 10 and 20 indicating a mildto-moderate withdrawal symptomatology (Sullivan et al., 1989).”
MethodInfluentialMayo-Smith, M. F. (1997) · JAMA · doi:10.1001/jama.278.2.144 · Cited by 434 · cited 2×
“…al., 2004; French et al., 2003), general anxiety disorder (Feltner et al., 2008; Montgomery et al., 2006; Pohl et al., 2005; Rickels et al., 2005) with regard to both psychic and somatic symptoms (Montgomery et al., 2006), social anxiety (Pande et al., 2003) and major depression (Showraki, 2007).”
BackgroundBaclofen in the Treatment of Alcohol Withdrawal Syndrome: A Comparative Study vs Diazepam
Addolorato, G., Leggio, L., Abenavoli, L., Agabio, R., Caputo, F., Capristo, E., Colombo, G., Gessa, G. L., & Gasbarrini, G. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.08.042 · Cited by 203
Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.7.848 · Cited by 176
Clorazepate and lorazepam: clinical improvement and rebound anxiety
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.3.312 · Cited by 50 · cited 1×
“In fact, these characteristics are in contrast with the occurrence of discontinuation symptoms and rebound anxiety when therapeutic doses of BDZs, considered the gold standard, are suspended after someweeks of therapy (Fontaine et al., 1984; Rickels et al., 1988).”
Background
Cited by
Lingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332
Gabapentin for the treatment of alcohol use disorder
Mason, B. J., Quello, S., & Shadan, F. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1417383 · Cited by 104
“Pregabalin (200–450 mg/d) has shown efficacy for treating uncomplicated alcohol withdrawal and related negative affective symptoms in one open-label study (N = 40)[83] and one multi-center, randomized, single-blind comparison trial with tiapride and lorazepam (N = 111) [84], as well as in a preclinical study of alcoho…”
Woods, A. D., Giometti, R., & Weeks, S. M. (2015) · JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/jbisrir-2015-1602 · Cited by 23
Metadata
- Authors
- Di Nicola, M., Martinotti, G., Tedeschi, D., Frustaci, A., Mazza, M., Sarchiapone, M., Pozzi, G., Bria, P., & Janiri, L.
- Venue
- Human Psychopharmacology: Clinical and Experimental
- Publisher
- Wiley
- Published
- 2010-03-30
- Volume
- 25
- Issue
- 3
- Pages
- 268-275
- ISSN
- 0885-6222 (ISSN-L)
- 1099-1077
- OpenAlex
- W1981941375
- Cited by
- 52
- References
- 5
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pregabalin in outpatient detoxification of subjects with mild‐to‐moderate alcohol withdrawal syndrome. https://app.cochat.ai/papers/10.1002/hup.1098
- The paper
- Di Nicola, M., Martinotti, G., Tedeschi, D., Frustaci, A., Mazza, M., Sarchiapone, M., Pozzi, G., Bria, P., & Janiri, L. (2010). Pregabalin in outpatient detoxification of subjects with mild‐to‐moderate alcohol withdrawal syndrome. Human Psychopharmacology: Clinical and Experimental. https://doi.org/10.1002/hup.1098
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.